RCKT Sells PRV for $180M, Extends Cash Runway to Q2 2028, Funds Cardiovascular Pipeline
Rocket Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.02
+7.0% in 7d after detection
Post-detection moves
1h
—
1d
+1.5%
3d
+3.8%
7d
+7.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS